Erectile Dysfunction Market, Global Outlook and Forecast 2022-2028

 Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

This report contains market size and forecasts of Erectile Dysfunction in global, including the following market information:

• Global Erectile Dysfunction Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Erectile Dysfunction Market Sales, 2017-2022, 2023-2028, (Million Pill)

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-erectile-dysfunction-forecast-2022-2028-177

The global Erectile Dysfunction market was valued at 5004.7 million in 2021 and is projected to reach US$ 7899.3 million by 2028, at a CAGR of 6.7% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sildenafil Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Erectile Dysfunction include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals and Seoul Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Erectile Dysfunction manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Erectile Dysfunction Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Million Pill)

Global Erectile Dysfunction Market Segment Percentages, by Type, 2021 (%)

• Sildenafil
• Tadalafil
• Others

Global Erectile Dysfunction Market, by Sales Channels, 2017-2022, 2023-2028 ($ Millions) & (Million Pill)

Global Erectile Dysfunction Market Segment Percentages, by Sales Channels, 2021 (%)

• Hospital Pharmacies
• Private Clinics
• Retail Pharmacies
• E-Commerce (B2B)
• E-Commerce (B2C)

Global Erectile Dysfunction Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Million Pill)

Global Erectile Dysfunction Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Erectile Dysfunction revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Erectile Dysfunction revenues share in global market, 2021 (%)
• Key companies Erectile Dysfunction sales in global market, 2017-2022 (Estimated), (Million Pill)
• Key companies Erectile Dysfunction sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Pfizer
• Bayer
• BaiYunShan General Factory
• S.K. Chemicals
• Teva Pharma
• Dong-A ST
• Petros Pharmaceuticals
• Seoul Pharma
• Yabang Pharmacy

Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-erectile-dysfunction-forecast-2022-2028-177

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports